Skip to main content

BETHKIS

NDC 10122-820 · Chiesi USA, Inc.

Generic nametobramycin
Dosage formSOLUTION
RouteRESPIRATORY (INHALATION)
Active ingredient(s)TOBRAMYCIN
Strength300 mg/4mL
Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
Marketing categoryNDA

Packages

10122-820-04 — 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE

10122-820-28 — 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE

10122-820-56 — 14 POUCH in 1 CARTON (10122-820-56) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE

Billed under HCPCS

J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams Medicare Part B payment limit (ASP + 6%): $12.30

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0813 — tobramycin, 0078-0876 — tobramycin and dexamethasone, 0093-4085 — Tobramycin, 0574-4031 — tobramycin and dexamethasone, 16714-119 — Tobramycin Inhalation Solution, 24208-290 — Tobramycin, 24208-295 — Tobramycin and Dexamethasone, 24208-358 — loteprednol etabonate and tobramycin, 24492-850 — Tobramycin, 42571-408 — Tobramycin solution, 43598-605 — Tobramycin Inhalation Solution, 46708-518 — Tobramycin Ophthalmic Solution, 46708-801 — Loteprednol etabonate and Tobramycin, 47335-171 — Tobramycin, 49502-345 — Tobramycin, 49502-401 — Tobramycin, 50090-1135 — Tobramycin and Dexamethasone, 50090-1136 — Tobramycin and Dexamethasone, 50090-1914 — Tobramycin and Dexamethasone, 50090-2127 — Tobramycin, +58 more